title: [Type I and IV collagenases and their endogenous regulators in immortalized and transformed fibroblasts].
abstract: To elucidate the role of matrix metalloproteinases (MMP) in carcinogenesis, the expression of collagenases of types I (MMP-I) and IV (MMP-2 and MMP-9) as well as the behaviour of urokinase-like plasminogen activator (uPA) and of tissue MMP inhibitors (TIMP) in immortalized (IF) and transformed (TF) fibroblasts were investigated. The study was carried out using embryo rat fibroblasts, sequentially immortalized with the LT gene of human papilloma virus and transformed with the E7 gene of human papilloma virus (HPV-16). As control was used the primary fibroblast (PF) culture of Fisher rats. In IF, the collagenase activity was at the same level as it was in PF. The activity of uPA in IF was increased by 2-2.5-fold; the titrated amount of free endogenous inhibitors in IF and PF was at essentially the same level while being markedly higher than in TF. At the stage of fibroblast transformation with the E7 gene of HPV-16, there was seen an increase of Type IV collagenases and a decrease of Type I collagenase, both these indices being most pronounced in the cells with most developed tumorigenic properties. In TF there occurred a decrease of free endogenous MMP inhibitors relative to the enzyme activity and, at the same time, a decrease in uAF activity, indicating the changes occurring in the enzyme/inhibitor/activator ratio and hence the enhancement of the destructive potential of the cells (in this case, at the cost of Type IV collagenase activity).
authors.affiliation: Orekhovich Institute of Biomedical Chemistry, RAMS, Russia.
authors.forename: N I
authors.initials: NI
authors.lastname: Solov'eva
authors.forename: S V
authors.initials: SV
authors.lastname: Vinokurova
authors.forename: E A
authors.initials: EA
authors.lastname: Dilakian
authors.forename: T A
authors.initials: TA
authors.lastname: Gureeva
authors.forename: V A
authors.initials: VA
authors.lastname: Zhurbitskaia
authors.forename: T O
authors.initials: TO
authors.lastname: Balaevskaia
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D004789:Enzyme Activation; D005347:Fibroblasts; D006868:Hydrolysis; D020781:Matrix Metalloproteinase 1 / Q000096:biosynthesis*; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis*; D061965:Matrix Metalloproteinase Inhibitors; D010662:Phenylmercuric Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D013439:Sulfhydryl Reagents; C010024:4-aminophenylmercuriacetate; D014357:Trypsin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D020781:Matrix Metalloproteinase 1; D010662:Phenylmercuric Acetate